Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia

Pediatric Infectious Disease Journal

Volumn 28, Issue 12, 2009, Pages 1064-1068

  Afzal, Samina ^a   Ethier, Marie Chantal ^b   Dupuis, L Lee ^a,b,c   Tang, Laureen ^a   Punnett, Angela S ^a   Richardson, Susan E ^d   Allen, Upton ^a,b   Abla, Oussama ^a   Sung, Lillian ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Department of Child Health Evaluative Sciences ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Division of Microbiology   (Canada)

Author keywords

Acute lymphoblastic leukemia; Children; Induction; Infection; Risk factors

Indexed keywords

ASPARAGINASE; CORTICOSTEROID; DAUNORUBICIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD LEUKEMIA; DOWN SYNDROME; FEMALE; FEVER; HUMAN; INFECTION; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION;

EID: 74049127846     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181aa6eae     Document Type: Article

References (17)

1. Jones GR, Konsler GK, Dunaway RP, et al. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol. 1996;13: 217-229.
2. Rahiala J, Perkkio M, Riikonen P. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients. Pediatr Hematol Oncol. 1998;15:165-174.
3. Christensen MS, Heyman M, Mottonen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol. 2005;131:50-58.
4. Wehl G, Allerberger F, Heitger A, et al. Trends in infection morbidity in a pediatric oncology ward, 1986-1995. Med Pediatr Oncol. 1999;32:336-343.
5. Meir HM, Balawi IA, Meer HM, et al. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy. Saudi Med J. 2001;22:423-427.
6. Wheeler K, Chessells JM, Bailey CC, et al. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X. Arch Dis Child. 1996;74:101-107.
7. Lausen B, Schmiegelow K, Andreassen B, et al. Infections during induction therapy of childhood acute lymphoblastic leukemia-no association to mannose-binding lectin deficiency. Eur J Haematol. 2006;76: 481-487.
8. Lex C, Korholz D, Kohlmuller B, et al. Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma-a rationale for tailored supportive care. Support Care Cancer. 2001;9:514-521.
9. Hughes WT, Pizzo PA, Wade JC, et al; Infectious Diseases Society of America and the Food and Drug Administration. Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Clin Infect Dis. 1992;15:S206-S215.
10. Bone RC, Balk RA, Cerra FB, et al; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [comment]. Chest. 1992;101:1644-1655.
11. Garner JS, Jarvis WR, Emori TG, et al. CDC Definitions for Nosocomial Infections. St. Louis, MO: Mosby; 1996.
12. Katsimpardi K, Papadakis, Pangalis A, et al. Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Supportive Care in Cancer. 2006;14;277-284.
13. De Pauw BE, Deresinski SC, Feld R, et al; The Intercontinental Antimicrobial Study Group. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer: a multicenter randomized trial. [comment]. Ann Intern Med. 1994;120:834-844.
14. Anneren G, Magnusson CG, Lilja G, et al. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child. 1992;67:628-631.
15. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. [comment]. Clin Infect Dis. 2002;34:730-751.
16. Ammann RA, Hirt A, Luthy AR, et al. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003;41:436-443.
17. Talcott JA, Siegel RD, Finberg R, et al. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol. 1992;10:316-322.